GCP-enheden ved Københavns Universitetshospital
GCP-enheden ved Københavns Universitetshospital is recorded as a service provider in 40 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 20 of 40 trials · Latest update first
The GOAL study: GLP-1 receptor agonist treatment for Adolescents with Obesity secondary to Antipsychotic Medication - A feasibility study
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Pragmatic Randomized Trial to Evaluate the Effect of Recombinant Herpes Zoster Vaccine on Major Adverse Cardiovascular Events and Dementia in Adults Aged 65 Years or Above
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 4, Pragmatic, Randomized Trial to Evaluate the Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years (DAN-COMBO)
Sponsor Gentofte Hospital
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP 2)
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients with Stage I-III dMMR Colon Cancer
Sponsor Region Sjaelland
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
SEMAGONA: A randomized four-arm parallel group double-blind double dummy 52-week clinical trial comparing the effects of s.c. Semaglutide 2.4 mg once-weekly, i.m. testosterone undecanoate 1,000 mg every 13th week, combination of s.c. Semaglutide 2.4 mg once-weekly and i.m. testosterone undecanoate 1,000 mg every 13th week, and placebo on body composition and hypogonadal symptoms in men with obesity-associated functional hypogonadism
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Gabapentin for sub-acute radicular leg pain (GABARAD)
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Operational learnings available5 trial-level findings · Read insights
- Only 15 participants were enrolled over 21 months versus the planned sample size of 200.
- General practitioners and other departments referred fewer patients than expected despite repeated outreach and recruitment efforts.
- Newspaper and social-media advertising through Trialtree was attempted, but the cost per enrolled participant was too high for the study budget.
- Most patients routinely referred to the three departments had already received gabapentin or pregabalin and were therefore excluded.
- The available dataset was too small for meaningful protocol-specified statistical analysis, and no statistical report was produced in agreement with Danish authorities.
These findings describe the trial, not the service provider’s performance or responsibility.
A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19 (DAN-COVID)
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Remifentanil versus rocuronium for optimizing video laryngoscopy assisted tracheal intubation in patients undergoing general anaesthesia - a multicentre randomised controlled trial The ROCVIDEO trial
Sponsor Nordsjaellands Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
SemenGlutide: A randomized double-blinded, placebo-controlled, single-center, clinical trial comparing the effects of s.c. Semaglutide 2.4 mg once-weekly versus placebo on sperm concentration in overweight infertile men
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
COLchicine and non-enteric coated aspirin in the Cardiovascular Outcomes Trial of patients with Type 2 Diabetes (COLCOT-T2D)
Sponsor Montreal Heart Institute
- Start (EU)
- Latest update
- Estimated end
FIT-HF - Effect of weight loss on physical and cardiac performance in people with obesity and heart failure
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
S-KETamine vs. propofol for prehospital sedation of patients with severe Acute Brain Injury: The KETABI randomised trial
Sponsor Region Hovedstaden
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Obesity and Semaglutide in Type 1 Diabetes Therapy (OBES1TY): A Multicentre, Randomised, Double-Blinded, Placebo-Controlled, Investigator-Initiated Trial
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
Advancing the quality of treatment and care for acute agitation in emergency psychiatry
Sponsor Region Hovedstaden
- Start (EU)
- Latest update
- Estimated end
- Not reported
Using live vaccines to induce beneficial innate immune training and reduce systemic inflammation in COPD patients (COPD-LIVE)
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 18 Years or Above (DAN-RSV)
Sponsor Gentofte Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
HOVON 178 WM: A prospective phase I/II trial of epcoritamab in patients with relapsed or refractory Waldenstrom’s macroglobulinemia
Sponsor Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
- Start (EU)
- Latest update
- Estimated end
- Not reported
The NOVA-NOA Trial A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia
Sponsor Herlev Hospital
- Start (EU)
- Latest update
- Estimated end
- Not reported
Early shift to oral antibiotic treatment of pyogenic vertebral osteomyelitis – a open label non-inferiority randomized nationwide study.
Sponsor Rigshospitalet
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for GCP-enheden ved Københavns Universitetshospital?
The 2026-10-09 snapshot links GCP-enheden ved Københavns Universitetshospital to 40 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Safety reporting & pharmacovigilance, Data management, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for GCP-enheden ved Københavns Universitetshospital?
The most frequently recorded therapeutic areas are Metabolic Disorders, Infectious Disease, Cardiology, Endocrinology. Recorded phases include Phase 4, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to GCP-enheden ved Københavns Universitetshospital conducted?
The linked trials record locations in 13 countries, including Denmark, Spain, Finland, France, Norway. These are trial locations, not confirmed office locations or countries where GCP-enheden ved Københavns Universitetshospital delivered services.
What can this page tell me about GCP-enheden ved Københavns Universitetshospital's trial experience?
Browse 40 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under GCP-enheden ved Københavns Universitetshospital. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- GCP-enheden ved Københavns Universitetshospital